Search

MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region that acts as a regulator of metabolic homeostasis and insulin sensitivity. It is not FDA-approved and has not been studied in published human efficacy randomized controlled trials; current evidence is preclinical, with rodent studies linking it to improved metabolic and exercise-related outcomes.